These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 9513735

  • 1. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study.
    Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL.
    Biol Psychiatry; 1998 Feb 15; 43(4):263-9. PubMed ID: 9513735
    [Abstract] [Full Text] [Related]

  • 2. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun 15; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 15; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 4. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
    Szulc A, Galińska B, Tarasów E, Kubas B, Dzienis W, Konarzewska B, Poplawska R, Tomczak AA, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 15; 13 Suppl 1():17-22. PubMed ID: 17507880
    [Abstract] [Full Text] [Related]

  • 5. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2009 Feb 15; 15(2):CR82-88. PubMed ID: 19179972
    [Abstract] [Full Text] [Related]

  • 6. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.
    Neuroimage; 2004 Apr 15; 21(4):1781-9. PubMed ID: 15050598
    [Abstract] [Full Text] [Related]

  • 7. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.
    Pharmacopsychiatry; 2011 Jun 15; 44(4):148-57. PubMed ID: 21710405
    [Abstract] [Full Text] [Related]

  • 8. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
    Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW.
    Biol Psychiatry; 1998 Apr 01; 43(7):483-8. PubMed ID: 9547926
    [Abstract] [Full Text] [Related]

  • 9. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
    Schweinsburg BC, Taylor MJ, Alhassoon OM, Videen JS, Brown GG, Patterson TL, Berger F, Grant I.
    Alcohol Clin Exp Res; 2001 Jun 01; 25(6):924-34. PubMed ID: 11410730
    [Abstract] [Full Text] [Related]

  • 10. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.
    Atmaca M, Yildirim H, Ozdemir H, Ogur E, Tezcan E.
    Psychol Med; 2007 Jan 01; 37(1):121-9. PubMed ID: 17094813
    [Abstract] [Full Text] [Related]

  • 11. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep 01; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 12. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Siergiejczyk L, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 01; 13 Suppl 1():11-6. PubMed ID: 17507879
    [Abstract] [Full Text] [Related]

  • 13. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK.
    Drug Alcohol Depend; 2007 Apr 17; 88(1):28-35. PubMed ID: 17084995
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
    Başoğlu C, Cetin M, Oner O, Ebrinç S, Semiz UB, Kandilcioğlu H, Silit E, Kizilkaya E.
    Turk Psikiyatri Derg; 2006 Apr 17; 17(2):85-91. PubMed ID: 16755408
    [Abstract] [Full Text] [Related]

  • 15. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N, Morales H, Modrego PJ, Muñoz-Mingarro J.
    Acad Radiol; 2006 Feb 17; 13(2):229-35. PubMed ID: 16428059
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.
    Psychiatr Pol; 2003 Feb 17; 37(6):977-88. PubMed ID: 14727370
    [Abstract] [Full Text] [Related]

  • 17. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 18. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia.
    Tibbo P, Hanstock CC, Asghar S, Silverstone P, Allen PS.
    J Psychiatry Neurosci; 2000 Nov 30; 25(5):509-12. PubMed ID: 11109301
    [Abstract] [Full Text] [Related]

  • 19. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 30; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 20. Neuronal dysfunction of the frontal lobe in schizophrenia.
    Pae CU, Choe BY, Joo RH, Lim HK, Kim TS, Yoo SS, Choi BG, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU.
    Neuropsychobiology; 2004 Dec 30; 50(3):211-5. PubMed ID: 15365217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.